AGL 38.70 Increased By ▲ 0.20 (0.52%)
AIRLINK 137.88 Increased By ▲ 0.99 (0.72%)
BOP 5.43 Increased By ▲ 0.03 (0.56%)
CNERGY 3.78 No Change ▼ 0.00 (0%)
DCL 7.74 Decreased By ▼ -0.14 (-1.78%)
DFML 45.62 Decreased By ▼ -0.18 (-0.39%)
DGKC 80.50 Increased By ▲ 0.15 (0.19%)
FCCL 29.55 Increased By ▲ 0.65 (2.25%)
FFBL 55.80 Decreased By ▼ -1.20 (-2.11%)
FFL 9.09 Decreased By ▼ -0.34 (-3.61%)
HUBC 105.60 Increased By ▲ 1.86 (1.79%)
HUMNL 14.05 Increased By ▲ 0.08 (0.57%)
KEL 4.30 Increased By ▲ 0.58 (15.59%)
KOSM 8.23 Decreased By ▼ -0.01 (-0.12%)
MLCF 37.98 Increased By ▲ 0.58 (1.55%)
NBP 69.23 Increased By ▲ 0.83 (1.21%)
OGDC 167.00 Increased By ▲ 0.40 (0.24%)
PAEL 25.20 Increased By ▲ 0.19 (0.76%)
PIBTL 6.78 Decreased By ▼ -0.27 (-3.83%)
PPL 130.35 Increased By ▲ 0.99 (0.77%)
PRL 23.76 Increased By ▲ 0.09 (0.38%)
PTC 15.70 Decreased By ▼ -0.15 (-0.95%)
SEARL 61.48 Increased By ▲ 0.68 (1.12%)
TELE 7.04 Increased By ▲ 0.03 (0.43%)
TOMCL 36.10 Increased By ▲ 0.21 (0.59%)
TPLP 7.81 Decreased By ▼ -0.05 (-0.64%)
TREET 15.15 Increased By ▲ 0.09 (0.6%)
TRG 44.89 Decreased By ▼ -0.01 (-0.02%)
UNITY 25.51 Increased By ▲ 0.11 (0.43%)
WTL 1.27 Increased By ▲ 0.04 (3.25%)
BR100 9,223 Increased By 22.5 (0.24%)
BR30 27,766 Increased By 205.8 (0.75%)
KSE100 86,467 Increased By 409.1 (0.48%)
KSE30 27,163 Increased By 118.7 (0.44%)

LONDON: European equities fell in opening deals on Tuesday after the head of Moderna warned current coronavirus vaccines might be less effective at fending off the Omicron variant.

In initial trade, London’s benchmark FTSE 100 index reversed 0.9 percent to 7,047.14 points.

In the eurozone, Frankfurt’s DAX shed 0.9 percent to 15,137.86 points and the Paris CAC 40 lost 1.1 percent to 6,702.83.

Asian bourses and oil prices also took a tumble following the remarks.

Moderna chief executive Stephane Bancel’s comments, in an interview with the Financial Times, sent traders running for cover.

“There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,” he told the daily business newspaper.

The high amount of mutations on Omicron and its swift spread in South Africa indicated the present jabs would need to be tweaked, he indicated.

“Bancel ... predicted existing vaccines would struggle with the Omicron variant,” said CMC Markets analyst Michael Hewson.

The Moderna chief “warned it would take months for pharmaceutical companies to manufacture enough jabs at a sufficient scale to make a difference”, Hewson added.

“His tone contrasts with the likes of Pfizer and BioNTech was suggested any new vaccine would be able to modified fairly quickly.”

Comments

Comments are closed.